Pyrimidine

Pyrimidine

SCHEMBL6803514

O=C1C=CN=N1.c1cncnc1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL888329 0.86 TSHR (0.41)
SCHEMBL57549 0.83
Benzene SCHEMBL29147760 0.80
Ammonia Solution, Strong SCHEMBL3496230 0.80
Hydrochloric Acid SCHEMBL1554036 0.80
SCHEMBL2221687 0.80
Methane SCHEMBL222390 0.80
Methane SCHEMBL190374 0.80
Lithium SCHEMBL17474380 0.80
Naphthalene SCHEMBL3488504 0.74 CYP2A6 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112142748-A Pyrazolone pyrimidine compound, preparation method and application thereof 上海医药集团股份有限公司 2020-12-29 CN claimed
CN-112142763-A Pyrazolone pyrimidine compound, preparation method and application thereof 上海医药集团股份有限公司 2020-12-29 CN claimed
CN-112142747-A Pyrazolone pyrimidine compound, preparation method and application thereof 上海医药集团股份有限公司 2020-12-29 CN claimed
CN-1426776-A Composition for oxidation dyeing of keratin fibre OREAL (FR) 2003-07-02 CN claimed
CN-112142748-A Pyrazolone pyrimidine compound, preparation method and application thereof 上海医药集团股份有限公司 2020-12-29 CN disclosed
CN-112142763-A Pyrazolone pyrimidine compound, preparation method and application thereof 上海医药集团股份有限公司 2020-12-29 CN disclosed
CN-112142748-A Pyrazolone pyrimidine compound, preparation method and application thereof 上海医药集团股份有限公司 2020-12-29 CN disclosed
CN-112142763-A Pyrazolone pyrimidine compound, preparation method and application thereof 上海医药集团股份有限公司 2020-12-29 CN disclosed
CN-112142747-A Pyrazolone pyrimidine compound, preparation method and application thereof 上海医药集团股份有限公司 2020-12-29 CN disclosed
CN-112142747-A Pyrazolone pyrimidine compound, preparation method and application thereof 上海医药集团股份有限公司 2020-12-29 CN disclosed
CN-112142748-A Pyrazolone pyrimidine compound, preparation method and application thereof 上海医药集团股份有限公司 2020-12-29 CN disclosed
CN-112142763-A Pyrazolone pyrimidine compound, preparation method and application thereof 上海医药集团股份有限公司 2020-12-29 CN disclosed
CN-101711866-A Method for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies HENENTECH INC 2010-05-26 CN disclosed
CN-101098889-A Antibody induced cell membrane wounding PALINGEN INC (US) 2008-01-02 CN disclosed
CN-1878568-A Enhanced B cell cytotoxicity of CDIM binding antibody PALINGEN INC (US) 2006-12-13 CN disclosed
CN-1835768-A Methods of identifying tumors responsive to treatment with anti-ErbB 2 antibodies GENENTECH INC (US) 2006-09-20 CN disclosed
CN-1267790-C Automatic developing device and method for supplementing developing liquid FUJI PHOTO FILM CO LTD (JP) 2006-08-02 CN disclosed
CN-1771026-A Drug delivery system comprising an encapsulated active ingredient PROCTER & GAMBLE (US) 2006-05-10 CN disclosed
US-20040121952-A1 Treatment of cancer CHILDREN'S MEDICAL CENTER CORPORATION (US) 2004-06-24 US disclosed
CN-1312490-A Automatic developing device and method for supplementing developing liquid FUJI PHOTO FILM CO LTD (JP) 2001-09-12 CN disclosed